Overview

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Atorvastatin for prevention of acute GVHD
Phase:
Phase 2
Details
Lead Sponsor:
Mehdi Hamadani
West Virginia University
Treatments:
Atorvastatin
Atorvastatin Calcium
Calcium